Industry: Next-Gen Sequencing Draft Guidances Have Good Ideas But Need Tweaks

The 37 groups and individuals who submitted comments on FDA’s two draft guidances on next-generation sequencing issued in July expressed appreciation for the thinking behind the guidances, but found bones to pick with some details.